# KWF Implementation of Biomarkers 2026

**Funder:** KWF
**Budget:** Up to €500,000
**Deadline:** 24 March 2026 (Full proposal 12:00 noon. Phase III / implementation.)
**Duration:** 3-4 years
**Consortium:** Multidisciplinary team
**Application:** 2-stage
**TRL:** 6-7
**Frequency:** Annual
**Next round:** 2027-06
**Official call:** https://www.kwf.nl/en/forresearchers/funding/implementation-of-biomarkers-2026
**Last verified:** 14 June 2026

## Summary

The KWF Implementation of Biomarkers call funds multidisciplinary teams to move validated biomarkers toward real-world clinical use, with up to €500,000 over 3-4 years. This is a Phase III/implementation-focused call targeting projects at TRL 6-7, seeking to bridge the gap between proof-of-concept and clinical adoption. KWF runs this annually, with the 2027 round opening in June.

## Who should apply

- Multidisciplinary teams (lab scientists, clinicians, health-system partners)
- Projects with validated biomarker candidates ready for clinical implementation
- Researchers at academic medical centres, hospitals, or research institutes
- Teams willing to engage health-systems or clinical partners in implementation planning

## Key dates

- Full proposal deadline: 24 March 2026 (12:00 noon CET)
- Two-stage evaluation (pre-proposal followed by invited full proposal)
- Project duration: 3-4 years

## Tips for applicants

- Emphasize the implementation pathway from TRL 6-7 to clinical adoption; KWF prioritizes real-world feasibility and health-system readiness.
- Include named clinical and implementation partners (hospital, diagnostic lab, care pathway stakeholder) in the consortium; bench-only teams score lower.
- Address regulatory and cost-effectiveness angles explicitly, this funder wants evidence the biomarker will actually be used in practice.

## Frequently asked questions

### How much can I request from the KWF Implementation of Biomarkers call?

Up to €500,000 over a 3-4 year project period.

### Who should be involved in a KWF Implementation of Biomarkers team?

A multidisciplinary consortium including laboratory scientists, clinicians, and ideally health-system or clinical partner organisations committed to implementation.

### What stage of biomarker development does KWF Implementation of Biomarkers fund?

Projects at TRL 6-7 with validated biomarkers ready to move toward clinical implementation and real-world deployment.

### When is the next deadline for KWF Implementation of Biomarkers?

The full proposal deadline for 2026 is 24 March 2026; the next round is expected to open in June 2027.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/kwf-biomarkers-impl-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.